Artificial Intelligence to Accelerate Clinical Development

  • Thursday, 28 April 2022, 3:00 PM to 6:00 PM

With attrition rates high in drug development, increasing the costs and timescales it takes to get vital new drugs to patients, our panel will discuss examples of how artificial intelligence can help to accelerate this process, from screening meaningful biomarkers to more patient centric clinical trials.

15:00 Registration and Networking
15:30 Welcome
15:40 Panel Discussion on ‘Artificial Intelligence to Accelerate Clinical Development’
Chair: Julia Gwilt, Appleyard Lees
Joanne Hackett, IQVIA
Mark Hinton, Lucida Medical

16:40 Closing Remarks
16:45 Networking and Drinks
18:00 Close

Free to attend and open to all

Find out more from One Nucleus

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.